Oral Abstract Session 16: Hereditary Angioedema

Tuesday, 6 December 2011: 12:45 - 14:15
Gran Cancún 5 (Cancún Center)
Chairpersons:   Michael Frank (US) and Bruce Zuraw (US)
12:45 - 13:00
3181: Hereditary Angioedema and Normal C1-Inhibitor (HAE Type III): A Novel Mutation In the Coagulation Factor 12 Gene | Konrad Bork (Germany)
13:00 - 13:15
3182: Immuno-Safety of Recombinant Human C1 Inhibitor in Patients with Hereditary Angioedema: An Integrated Analysis Anurag Relan (Netherlands)
13:15 - 13:30
3183: Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary Angioedema Attacks Marc Riedl (US)
13:30 - 13:45
3184: Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Prophylaxis of Hereditary Angioedema (HAE) Attacks William Lumry (US)
13:45 - 14:00
3185: The Efficacy and Safety of Human Plasma-Derived C1-Inhibitor Concentrate Administered for the Treatment of Attacks in Pediatric Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency | Henriette Farkas (Hungary)
14:00 - 14:15
3186: Treatment of Idiopathic Nonhistaminergic Angiodema with Icatibant | Ramon Lleonart (Spain)
See more of: Oral Abstract Session
See more of: Abstract Presentations
<< Previous Session | Next Session >>